This is a beta site. Send your comments to info@pharmamkt.net

Radius: Off
Radius:
km Set radius for geolocation
Search

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi.

Finalised Agenda Released for Ophthalmic Drugs 2017

The wait is officially over, as SMi’s Ophthalmic Drugs has released the finalised agenda! A value-packed brochure with new pharma companies joining, including Santen Inc, Roche, Oxford BioMedica, Novartis, Aerie Pharmaceuticals and more, who will be presenting a vast range of topics and issues within ophthalmology. Our highly interactive, peer-led sessions will allow ophthalmic experts […]

What is patient-centricity… really?

Patient-centricity is a prominent buzzword but there is little consensus on the true purpose behind the engagement. eyeforpharma has addressed, the WHAT, the WHY, and the HOW behind patient-centricity in our latest magazine: WHAT: Guy Yeoman, VP Patient Centricity at AstraZenecaspeaks about how they have come to publish the first definition of patient centricity, co-created […]

Across the healthcare ecosystem the collective goal is clear – improve outcomes for patients

To do that we need to engage more stakeholders – payers, patients, support groups and families – while also providing more value to HCPs. On 23rd February, join this 1 hour webinar with eyeforpharma, Teva, Sanofi, AstraZeneca and Agnitio to explore how digital can: • Generate insights to help empower HCP-patient communication • Provide the […]

Pre-sale Questions